MIT researchers have developed a new mathematical method that could revolutionize the way blood pressure is managed during surgeries and intensive care. According to a study published in IEEE Transactions on Biomedical Engineering, this approach offers fast and accurate insights into the cardiovascular state, enabling doctors to quickly determine the best course of treatment during critical situations.
The study underscores the importance of determining not only whether blood pressure is abnormal but also why it has changed to adequately treat patients. Until now, healthcare professionals had to rely on less immediate and often more invasive methods to obtain this information. Emery N. Brown, the study’s senior author and a noted authority at MIT, Massachusetts General Hospital, and Harvard Medical School, told MIT News, "Any patient who is having cardiac surgery could need this."
At the heart of the method are the two key factors influencing blood pressure: cardiac output and systemic vascular resistance. By perfectly balancing these calculations, the new mathematical framework doesn't just provide consistent estimates at each heart beat but also maintains a high degree of accuracy. Lead author Taylor Baum, a graduate student at MIT, elaborated on the method's efficacy: "Our estimates, updated at every beat, are not just informed by the current beat; but they incorporate where things were in previous beats as well," as mentioned by MIT News.
This non-invasive technique has proven to be reliable in animal models, closely matching the output from more invasive procedures and showing potential to make significant strides in patient care. It is noteworthy that the technique demonstrated to consistently track the impacts of various drugs used to manage aberrant blood pressure, signaling an accurate reflection of physiological changes. With the goal of clinical application in sight, researchers are actively pursuing regulatory approval to bring this method into operating rooms and intensive care units. "Our approach provide information that can readily be used to guide hemodynamic management decisions in real time," the authors wrote in their paper, as reported by MIT News.
Encouraged by these advances, Baum and Brown's team is moving towards more comprehensive animal studies and, eventually, human clinical trials upon regulatory clearance. The broader implications for this research are vast, encompassing applications from heart surgeries and liver transplants to intensive care treatment. The development of a closed-loop system that precisely regulates blood pressure utilizing this methodology is also underway. As this innovation inches closer to reality, it holds the promise of better, safer, and more immediate care for patients experiencing critical blood pressure fluctuations.
